If you’re in pharma communications and you think you’re in the business of “building trust,” you’re already behind. The rules have changed. And the stakes have never been higher. Lee Carter offers a wake-up call for those in pharma comms… and five key shifts to make to resonate with patients today.
Today, one misstep in communication can cost you trust, customers, and credibility. Whether you’re navigating the unknowns of AI, political upheaval, or global market shocks, the difference between chaos and clarity comes down to one thing: how you communicate when it matters most.
On this episode of HearSay, we talk with Michelle Russo, EVP and Chief Communications and Marketing Officer at the U.S. Chamber of Commerce, about “Calming the Chaos.” Michelle has spent her career turning uncertainty into opportunity—and she shares some real-world communication strategies to help businesses not just survive, but win in this environment.
Consumer rage is surging. Customers feel betrayed–and people are reaching a breaking point. Across the country, once-trusted brands are raising prices, shrinking products, and making customer service harder to access. Playing short-term games with customer trust is a dangerous gamble. Michael Maslansky shares three principles to help companies do better by treating customers fairly.
There are moments in American politics when the ground shifts beneath our feet; when something that seemed fringe, even laughable, suddenly becomes the center of gravity. Today, that something is the MAHA movement: “Make America Healthy Again.” According to Lee Carter in this opinion piece for FoxNews.com, dismissing MAHA is not just shortsighted, it’s dangerous.
Every day, in boardrooms, break rooms, and across the internet, people are shaping their own version of your company’s story—whether it’s accurate or not. Here’s the hard truth: If you don’t own your narrative, someone else will. And when that happens, you can lose control—not just of your story, but of your brand, your reputation, and your future.
On this episode of HearSay, we dive into a critical question every business leader should be asking: Do you have a corporate narrative that truly defines you—or are you letting the world fill in the blanks? Join us, because the answer could be the difference between leading the conversation and being left behind.
News that RFK Jr. will push to change the childhood vaccine schedule is putting intense new scrutiny on recommendations. When pharma responds with “trust the science” or appeals to authority of the CDC’s past recommendations, these messages often fall flat—or worse, appear dismissive.
Does your company have a corporate narrative? Do you know it? Can people find it? And more importantly, is it the right one? Ben Feller suggests it may be time to see if your narrative is doing its job–and offers three ways to simplify the challenge of finding the right one.
The Make America Healthy Again (MAHA) Commission has dropped its roadmap, and while the headlines sound like the usual policy fare (“modernize vaccines,” “expand injury research,” “re-evaluate childhood schedules”), what’s really happening is a communications earthquake. Ignore it, and you do so at your own peril.
What’s in a name? Everything, if you consider the Trump administration’s decision to rechristen the Department of Defense to the Department of War. Lee Carter chimes in on the debate in this provocative thought piece.
In our work, we often hear terms like “insights,” “learnings,” and “findings” used interchangeably. But are they really the same? And does it matter which one you use?
The answer is no. And yes.
